chr16-74691302-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152649.4(MLKL):āc.697A>Gā(p.Lys233Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000496 in 1,611,430 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_152649.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MLKL | NM_152649.4 | c.697A>G | p.Lys233Glu | missense_variant | 4/11 | ENST00000308807.12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MLKL | ENST00000308807.12 | c.697A>G | p.Lys233Glu | missense_variant | 4/11 | 2 | NM_152649.4 | P1 | |
MLKL | ENST00000306247.11 | c.535+1040A>G | intron_variant | 1 | |||||
MLKL | ENST00000571303.1 | c.169A>G | p.Lys57Glu | missense_variant, NMD_transcript_variant | 1/6 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152116Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000604 AC: 15AN: 248478Hom.: 0 AF XY: 0.0000669 AC XY: 9AN XY: 134484
GnomAD4 exome AF: 0.0000541 AC: 79AN: 1459314Hom.: 1 Cov.: 31 AF XY: 0.0000523 AC XY: 38AN XY: 726136
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152116Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74302
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 28, 2022 | The c.697A>G (p.K233E) alteration is located in exon 4 (coding exon 3) of the MLKL gene. This alteration results from a A to G substitution at nucleotide position 697, causing the lysine (K) at amino acid position 233 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at